HOLDING STRONG!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL, it is fun to see ELTP with a little jump with early high volume causing some to get all flustered!!!
Prospect of continued increasing record revenue to be reported next week!
Elite has been quite and not putting out fluff news so we don't know what great things we may hear!
Fear of squeeze with a major rise in PPS is a valid CONCERN for those not in the right position!
SPREAD THE WORD!!! GET THE ELTP MESSAGE OUT THERE!!!
ALL DEDICATED ELTP INVESTORS MUST TALK ABOUT ELITE PHARMACEUTICALS EVERYWHERE THEY CAN!!!
GIVE THE FACTS - INCREASING REVENUE QUARTER AFTER QUARTER, CASH FLOW POSITIVE, GROWING THEIR MARKET BASE, ETC!!!
NO ONE IS DOING IT FOR US SO - GET THE WORD OUT!!!
Just saw a post regarding ELITE on reddit. We need more communications out there letting people know about ELTP and how undervalued/oversold Elite is.
We have to get the word out and generate INTEREST!
I have an account now but it will be 30 days before I can share anything.
Everyone that actually wants Elite to be known then we have to get the word out on the right message platforms that are hot and trending.
Get the word out and send them here to IHUB!!!
ELITE's revenues have been going up! ELITE's profits have been going up!
ELITE's stock price has been pushed down! ELITE's stock is way oversold!
ELITE should be trading at least in the 40 cent range!
If we say something on WSB and other retail investors decide to take a position in ELITE based on their own due diligence then I say spread the word!!!
ELITE could have a headline like this very soon!
"OMG “Tiny oil driller with 5 employees” becomes $128m company in three hours due to mention on WSB"and in the article "soaring nearly 1,000%".
Just a mention on wallstreetbets and a stock that has been abused for so long can be sky rocketing.
We need an ELITE army posting on reddit WSB!!!
ELITE in not overvalued, is increasing revenues and growing, and for longer than the the past year of trading has shown us how oversold ELITE is!
Read - "GameStop: History Points To A Share Price In The Thousands"
Yes, I am going back to the current situation with GameStop!
There are a lot of similarities with ELITE's situation.
Pay attention to the story and realize the power of this statement -
"That all changed when a mob of savvy retail investors realized that it wouldn't take much to ignite........"
That is exactly what ELITE needs to right the injustice that has plagued our stock for too long now!!!!!!!!
That is what ELITE needs a gamestop story!
Institutional big boys jump in to drive a stock down and then a huge group of retail investors connect on social media platforms to fight back.
Maybe ELTP is getting a following on WallStreetBets forum???
Maybe we will see ELITE's stock price run up like GameStop!!!
N2K, in support of controlling cost - "increase in gross margin is due to increased manufacturing efficiencies"
As stated in Elite's current report -
"Our gross profit margin was 49% during the three months ended September 30, 2020 as compared to 29% during the three months ended September 30, 2019. The increase in gross margin is due to increased manufacturing efficiencies of scale being achieved in relation to increased manufacturing volumes resulting in decreased unit overhead absorption rates, as compared to the comparable period of the prior year, combined with timing of in market sales by our marketing partner of the Amphetamine IR and Dantrolene products resulting in a higher level of related licensing fees during the three months ended September 30, 2020, as compared to the comparable period of the prior fiscal year."
So is Elite's amphetamine salts what is mentioned in Lannett Inc (LCI) Q4 2020 Earnings Call Transcript? CNS is up!!!
*******************************************
Scott Henry -- Roth Capital Partners -- Analyst
Okay. Final question. The CNS category was strong in 2020 fiscal year, but it tends to be a little more volatile, a lot more levers. How should we think about CNS for fiscal year 2021?
John Kozlowski -- Vice President of Finance and Chief Financial Officer
Well, if you see it in Q4, CNS is up and that's due to -- specifically due to one of our more recent launches, the amphetamine salts. And so as we look in 2021, we are expecting that category to grow starting in Q1 where we're getting a full quarter.
*******************************************
So, Lannett is expecting CNS amphetamine salts to GROW in their Q1 (July through September) which means MORE FOR ELTP!!!
JEEZZZ! Elite could buy with shares but SUNGEN wanted all CASH for their part of the adderall generics!
Carter was right - Elite's cash is needed for operations and R&D therefore they did not have the cash available!
It was smart to keep the focus on Elite's cash needs and not try to raise cash by dumping shares through Lincoln Park Capital. SUNGEN may not have waited for Elite to sell shares and may have already had a unknown bidder ready to offer cash so time was of concern.
Key is we do not know all the details and we never will as WE DO NOT HAVE THE LEGAL RIGHT to know it ALL!!! Get over it already! Things are still good for ELITE!!!
It is great that Nasrat bought SUNGEN's interest in the adderall generics as we know that he is committed to ELITE's success and will look out for ELITE's best interest as that is in his best interest. What if a SUNGEN sold their interest to someone that created problems for ELITE??
Elite still gets their share of the adderall generics!
Elite's revenue will continue to increase from the adderall generics!
Elite will have no problems with adderall generics as Nasrat is the new partner and not some unknown trouble maker!
Elite can focus their cash where they need it the most (i.e., getting the next 1.5 billion generic developed, approved, launched)!
ELTP recent time & sales
Date/Time Price Shares Buy/Sale
07/01/2020 13:18:10 EDT 0.0743 20000
07/01/2020 13:18:10 EDT 0.0743 700
07/01/2020 13:16:47 EDT 0.0743 800
07/01/2020 13:16:47 EDT 0.0743 3000 S
07/01/2020 13:16:45 EDT 0.075 10000
07/01/2020 13:16:43 EDT 0.075 20000 S
07/01/2020 13:16:42 EDT 0.08 33
07/01/2020 13:16:33 EDT 0.08 154100
07/01/2020 13:16:33 EDT 0.08 1750 S
07/01/2020 13:16:21 EDT 0.0801 10000 S
07/01/2020 13:05:39 EDT 0.0808 400 B
07/01/2020 13:04:28 EDT 0.08055 250 S
07/01/2020 13:03:39 EDT 0.0808 10000 S
07/01/2020 12:56:34 EDT 0.0815 48750
07/01/2020 12:45:27 EDT 0.0815 12812
07/01/2020 12:45:26 EDT 0.0815 47188
07/01/2020 12:41:54 EDT 0.0815 1000 B
07/01/2020 12:41:00 EDT 0.0808 89 S
07/01/2020 12:38:12 EDT 0.0815 10000 B
07/01/2020 12:38:12 EDT 0.0814 10000 S
07/01/2020 12:37:47 EDT 0.0815 460 S
07/01/2020 12:35:29 EDT 0.082 540 S
07/01/2020 12:28:22 EDT 0.0833 600 B
07/01/2020 11:57:04 EDT 0.08122 2180 S
07/01/2020 11:35:50 EDT 0.082 9000 B
07/01/2020 11:32:26 EDT 0.08077 5400 B
07/01/2020 11:24:28 EDT 0.0801 15000 S
07/01/2020 11:24:28 EDT 0.08077 5000 S
07/01/2020 11:18:56 EDT 0.0812 20000 S
07/01/2020 11:18:46 EDT 0.0815 2000
From Elite's conf call - some key exerts IMO!
**What I know and that is the quarter ending today (June 30, 2020 which will be reported around August 14, 2020) we will hit the $7 million in revenues and that quarter would not have any profit splits from the ER
**The growing concern -- there is no going concern opinion that's been removed and I mean the business and the financials demonstrate just why that was the case. We don't have that issue and on the internal controls, there were material weaknesses in internal controls in the 2019 10-K, all of which have been remediated.
*Revenues 137% % increase as compared to the last year. So clearly without a doubt these are our highest revenues, as well as the largest dollar increase in our revenues in Elite's history.
*Manufacturing revenues, those are earned when we make and we ship the product. So those increased from $5.4 million in 2019 to $14.5 million in 2020. It's a $9.1 million increase or a 166%.
*We do expect additional contribution from the extended release Adderall as those profit splits start to come online over the next few quarters. So you put the increases in both manufacturing revenues and profits put together, you get total revenues going up from $7.6 million to $18 million in a single year.
*Our marketing partner has done a great job with all of these products, but there's still room for growth in the future.
*We secured enough API quota from the DEA to support Lannett's sales projections through the end of this year. That is fantastic news. We struggled with that in the first quarter and a little bit in the second and finally the DEA came around and gave us enough quota to support the sales and marketing projections through the end of the year.
*Our sales and marketing partners Glenmark, TAGI and Lannett are all performing well.
*CNS, ANDA, what is the status of SunGen partnership CNS, ANDA with the potential of $1.5 billion market? As it would require a bio equivalency trial before submitting and we were led to believe this effort was on the front burner. Why the delay? Well, the delay is because SunGen is not putting in any money. So I reached an agreement with SunGen that we will take over this product. We have no further obligation to them. We are going to develop it to a point where we can run a clinical trial. And it will be 100% Elite's product.
*Yes. I think August 14th is the next filing date.
Gap just filled.... T&S below
Date/Time Price Shares Buy/Sale
06/30/2020 10:44:29 EDT 0.08975 100 S
Elite T&S updated with B-buy and S-sale
Date/Time Price Shares Buy/Sale
06/30/2020 10:34:26 EDT 0.09 1218
06/30/2020 10:33:43 EDT 0.09 1000
06/30/2020 10:25:54 EDT 0.09 400
06/30/2020 10:22:23 EDT 0.09 1420
06/30/2020 10:22:20 EDT 0.09 5000
06/30/2020 10:22:14 EDT 0.09 2500
06/30/2020 10:22:11 EDT 0.09 10000 S
06/30/2020 10:22:02 EDT 0.091 30000 B
06/30/2020 10:20:57 EDT 0.09 14000
06/30/2020 10:20:57 EDT 0.09 1000
06/30/2020 10:20:57 EDT 0.09 30000
06/30/2020 10:20:57 EDT 0.09 5000 S
06/30/2020 10:20:35 EDT 0.0907 10000 S
06/30/2020 10:20:16 EDT 0.091 10000 S
06/30/2020 10:19:55 EDT 0.092 2500 S
06/30/2020 10:18:50 EDT 0.0923 11322 B
06/30/2020 10:16:58 EDT 0.091 9500
06/30/2020 10:16:55 EDT 0.091 10000
06/30/2020 10:16:51 EDT 0.091 30500 S
06/30/2020 10:14:46 EDT 0.095 1000 B
06/30/2020 10:14:23 EDT 0.0937 1000 B
06/30/2020 10:14:07 EDT 0.0936 591 B
06/30/2020 10:12:53 EDT 0.093 100 S
06/30/2020 10:10:22 EDT 0.0935 500 B
06/30/2020 10:09:27 EDT 0.091 19550 S
06/30/2020 10:09:09 EDT 0.095 73 B
06/30/2020 10:07:08 EDT 0.0935 485 S
06/30/2020 10:06:32 EDT 0.0959 250 B
06/30/2020 10:01:41 EDT 0.0935 1000 S
06/30/2020 10:01:08 EDT 0.0959 125 B
06/30/2020 9:58:21 EDT 0.0935 1000 S
06/30/2020 9:55:57 EDT 0.096 200
06/30/2020 9:55:49 EDT 0.096 10000 S
06/30/2020 9:55:38 EDT 0.097 20000 B
06/30/2020 9:55:38 EDT 0.0965 20000 S
06/30/2020 9:54:33 EDT 0.097 830 B
06/30/2020 9:54:13 EDT 0.0965 2500 S
06/30/2020 9:54:02 EDT 0.097 9180 B
06/30/2020 9:52:54 EDT 0.0969 10000 S
06/30/2020 9:51:14 EDT 0.0978 4396 B
06/30/2020 9:50:55 EDT 0.0969 1000
06/30/2020 9:50:25 EDT 0.0969 563 S
06/30/2020 9:49:34 EDT 0.0978 400 B
06/30/2020 9:49:25 EDT 0.0969 1999 S
06/30/2020 9:48:48 EDT 0.0972 10000 S
06/30/2020 9:48:27 EDT 0.0978 10000
06/30/2020 9:48:27 EDT 0.0978 7000
06/30/2020 9:47:31 EDT 0.0978 3900 S
06/30/2020 9:46:45 EDT 0.0995 3800 B
06/30/2020 9:46:43 EDT 0.099 4997 B
06/30/2020 9:46:43 EDT 0.0989 2502
06/30/2020 9:46:42 EDT 0.0989 2500 B
06/30/2020 9:46:42 EDT 0.0975 2500 S
06/30/2020 9:45:17 EDT 0.0989 7499 B
06/30/2020 9:45:16 EDT 0.0975 2500 S
06/30/2020 9:44:44 EDT 0.0989 25000
06/30/2020 9:44:43 EDT 0.0989 7499 B
06/30/2020 9:44:43 EDT 0.0975 2500 S
06/30/2020 9:36:30 EDT 0.0976 2700 B
06/30/2020 9:35:29 EDT 0.097 2000 B
06/30/2020 9:34:44 EDT 0.095 215
06/30/2020 9:34:06 EDT 0.095 5900 S
06/30/2020 9:33:59 EDT 0.099 4100 S
06/30/2020 9:32:55 EDT 0.0993 1000 B
06/30/2020 9:32:26 EDT 0.095 40000 S
06/30/2020 9:32:06 EDT 0.099 141000 S
06/30/2020 9:32:01 EDT 0.0995 1 B
06/30/2020 9:31:56 EDT 0.099 10000
06/30/2020 9:31:40 EDT 0.099 85000
06/30/2020 9:31:38 EDT 0.099 100000
06/30/2020 9:30:53 EDT 0.099 20000
06/30/2020 9:30:50 EDT 0.099 40000
06/30/2020 9:30:27 EDT 0.099 10600 B
06/30/2020 9:30:27 EDT 0.098 30000 B
06/30/2020 9:30:08 EDT 0.097 20000 S
06/30/2020 9:30:07 EDT 0.0972 1000
06/30/2020 9:30:07 EDT 0.0972 12000
06/30/2020 9:30:07 EDT 0.0972 20000
06/30/2020 9:30:07 EDT 0.0972 29915 B
06/30/2020 9:30:02 EDT 0.09 5000 S
06/30/2020 9:30:00 EDT 0.098 30000
Elite time and sales below
Date/Time Price Shares
06/30/2020 10:34:26 EDT 0.09 1218
06/30/2020 10:33:43 EDT 0.09 1000
06/30/2020 10:25:54 EDT 0.09 400
06/30/2020 10:22:23 EDT 0.09 1420
06/30/2020 10:22:20 EDT 0.09 5000
06/30/2020 10:22:14 EDT 0.09 2500
06/30/2020 10:22:11 EDT 0.09 10000
06/30/2020 10:22:02 EDT 0.091 30000
06/30/2020 10:20:57 EDT 0.09 14000
06/30/2020 10:20:57 EDT 0.09 1000
06/30/2020 10:20:57 EDT 0.09 30000
06/30/2020 10:20:57 EDT 0.09 5000
06/30/2020 10:20:35 EDT 0.0907 10000
06/30/2020 10:20:16 EDT 0.091 10000
06/30/2020 10:19:55 EDT 0.092 2500
06/30/2020 10:18:50 EDT 0.0923 11322
06/30/2020 10:16:58 EDT 0.091 9500
06/30/2020 10:16:55 EDT 0.091 10000
06/30/2020 10:16:51 EDT 0.091 30500
06/30/2020 10:14:46 EDT 0.095 1000
06/30/2020 10:14:23 EDT 0.0937 1000
06/30/2020 10:14:07 EDT 0.0936 591
06/30/2020 10:12:53 EDT 0.093 100
06/30/2020 10:10:22 EDT 0.0935 500
06/30/2020 10:09:27 EDT 0.091 19550
06/30/2020 10:09:09 EDT 0.095 73
06/30/2020 10:07:08 EDT 0.0935 485
06/30/2020 10:06:32 EDT 0.0959 250
06/30/2020 10:01:41 EDT 0.0935 1000
06/30/2020 10:01:08 EDT 0.0959 125
06/30/2020 9:58:21 EDT 0.0935 1000
06/30/2020 9:55:57 EDT 0.096 200
06/30/2020 9:55:49 EDT 0.096 10000
06/30/2020 9:55:38 EDT 0.097 20000
06/30/2020 9:55:38 EDT 0.0965 20000
06/30/2020 9:54:33 EDT 0.097 830
06/30/2020 9:54:13 EDT 0.0965 2500
06/30/2020 9:54:02 EDT 0.097 9180
06/30/2020 9:52:54 EDT 0.0969 10000
06/30/2020 9:51:14 EDT 0.0978 4396
06/30/2020 9:50:55 EDT 0.0969 1000
06/30/2020 9:50:25 EDT 0.0969 563
06/30/2020 9:49:34 EDT 0.0978 400
06/30/2020 9:49:25 EDT 0.0969 1999
06/30/2020 9:48:48 EDT 0.0972 10000
06/30/2020 9:48:27 EDT 0.0978 10000
06/30/2020 9:48:27 EDT 0.0978 7000
06/30/2020 9:47:31 EDT 0.0978 3900
06/30/2020 9:46:45 EDT 0.0995 3800
06/30/2020 9:46:43 EDT 0.099 4997
06/30/2020 9:46:43 EDT 0.0989 2502
06/30/2020 9:46:42 EDT 0.0989 2500
06/30/2020 9:46:42 EDT 0.0975 2500
06/30/2020 9:45:17 EDT 0.0989 7499
06/30/2020 9:45:16 EDT 0.0975 2500
06/30/2020 9:44:44 EDT 0.0989 25000
06/30/2020 9:44:43 EDT 0.0989 7499
06/30/2020 9:44:43 EDT 0.0975 2500
06/30/2020 9:36:30 EDT 0.0976 2700
06/30/2020 9:35:29 EDT 0.097 2000
06/30/2020 9:34:44 EDT 0.095 215
06/30/2020 9:34:06 EDT 0.095 5900
06/30/2020 9:33:59 EDT 0.099 4100
06/30/2020 9:32:55 EDT 0.0993 1000
06/30/2020 9:32:26 EDT 0.095 40000
06/30/2020 9:32:06 EDT 0.099 141000
06/30/2020 9:32:01 EDT 0.0995 1
06/30/2020 9:31:56 EDT 0.099 10000
06/30/2020 9:31:40 EDT 0.099 85000
06/30/2020 9:31:38 EDT 0.099 100000
06/30/2020 9:30:53 EDT 0.099 20000
06/30/2020 9:30:50 EDT 0.099 40000
06/30/2020 9:30:27 EDT 0.099 10600
06/30/2020 9:30:27 EDT 0.098 30000
06/30/2020 9:30:08 EDT 0.097 20000
06/30/2020 9:30:07 EDT 0.0972 1000
06/30/2020 9:30:07 EDT 0.0972 12000
06/30/2020 9:30:07 EDT 0.0972 20000
06/30/2020 9:30:07 EDT 0.0972 29915
06/30/2020 9:30:02 EDT 0.09 5000
06/30/2020 9:30:00 EDT 0.098 30000
n2k, I am with you on that. Was expecting more! Was it COVID on ? Was it COVID related impacts to the distribution network and our partners' difficulties? Was it DEA quota to ELITE? Was it difficulty in getting active pharmaceutical ingredients to manufacture ELITE's products? Was it needing additional shifts to manufacture more products?
Got to admit that staying flat in January to March 2020 is still good considering how CRAZY the whole world is right now!
Not worried as ELITE is in business and working and GROWING!!!
Just imagine what they can do if we get back to some kind of normal.
ELITE got a 137% YOY increase with little ole Adderall ER and a $400M market.
Adderall XR will give an ADDITIONAL 445% increase to ELITE with a $1.3 BILLION market!
August 2020 10Q quarterly report is just 6 weeks away or approximately reporting on August 11th (best guess)!!!
We did see some bigger spreads in ELTP trading. 0.07 to 0.08 vs 0.0XXXXX, one penny spread vs sub-sub-sub penny spreads.
Was that GTS???
If GTS sticks around and we have a good 10-K and expecting a great August 10-Q, there could be huge run up coming!
Could GTS be joining in because they see a HUGE jump in ELTP's share price coming???
The MM that showed up on ELITES trades GTSM is GTS. GTS is a leading global electronic market maker, powered by combining market expertise with innovative, proprietary technology.
GTS is one of the top MMs on NYSE so why is this BIG player working their high speed trading on ELTP???
Cut from something I found for GTS and OTC trading.....
That's starting to change thanks to efforts by some of Wall Streets most sophisticated players applying technology to the outdated market. Citadel Securities, Virtu Financial, Jane Street, and GTS ranked in the top five in ADR trading for notional amount and number of trades in July on OTC Markets' alternative trading system. G1 Execution Services, a subsidiary of Susquehanna, fell just outside the top five for both categories.
There is no doubt about the opportunity in the market. ADRs pricing spreads can often be much wider than listed stocks as brokers account for the risk that comes with conducting the labor-intensive trades. As a result, some investors choose to steer clear of ADRs entirely, or trade sparingly, despite interest in the companies.
GTS is one of the more recent entrants into the space, following its acquisition of Cantor Fitzgerald's wholesale market-making business in November 2018. Joe Pleffner, a principal in GTS' wholesale market-making business who came over as part of the Cantor deal, stressed that while trading ADRs has greatly evolved over the years, it's still not a pure speed game, as is commonly the case for listed equities.
Technology and humans are equally important to GTS' growth in the space, he added.
"Just because I am really fast in OTC markets doesn't mean I am really efficient in giving my customers the best price," Pleffner told Business Insider. "In some instances, especially OTC securities and even small caps, speed is not really beneficial to the investor. It is really where can I add more liquidity. Where can I give the best price to my clients. A lot of times the lack of speed kind of helps."
freerealtime has time&sales for ELTP.
It is really interesting to look at the sales and buys.
Someone buys at 0.08 and it is followed by a dump at 0.07
WOW, look at the ELTP games on level 2 buys/sells!
This IS a coordinated hit to steal shares!!!
Will be interesting to see the % shorted for today.
10K release Friday June 26 after market close with CC on Monday.
Just my guess!
Sharkey1 - Control number! Use the control number (16 digits) as the CUSIP (9 digits) probably will not get you in to Elite's meeting.
In the email I received from TDAmeritrade it shows-
ELITE PHARMACEUTICALS, INC. has issued proxy materials for its 2020 Special Meeting of shareholders.
Meeting Date: June 23, 2020
Record Date: April 27, 2020
CUSIP Number: XXXXXXXXX
Control Number: XXXXXXXXXXXXXXXX
The CONTROL NUMBER for the ELTP shareholder meeting is on the email you received for the proxy vote!
To attend the meeting, go to https://web.lumiagm.com/289761342, click on “I have a login,” enter the CONTROL NUMBER found on your proxy card you previously received, and enter the password “elite2020”
ELTP SEC Annual Report 10-Q previous dates
2019-06-21
2018-06-14
2017-06-14
2016-06-15
2015-06-15
2014-06-30
2013-06-21
2012-06-29
2011-06-29
Elite is not late! Could be tomorrow, could in two weeks from tomorrow.
ELITE's volume of shares
shorted on the below days is crazy!
May 29th Short-462,356 - 45% of total Vol Shorted
May 26th Short-832,408 - 87% of total Vol Shorted
May 22nd Short-227,101 - 88% of total Vol Shorted
May 21st Short-175,222 - 51% of total Vol Shorted
May 18th Short-465,898 - 68% of total Vol Shorted
May 15th Short-352,900 - 74% of total Vol Shorted
May 14th Short-201,588 - 57% of total Vol Shorted
May 13th Short-313,654 - 55% of total Vol Shorted
May 12th Short-418,014 - 66% of total Vol Shorted
May 05th Short-650,501 - 66% of total Vol Shorted
Thanks JB
Profit sharing payments will really start to show in Elite's June report so operating cost should be under control and better revenue coming in.
For those screaming dilution - go back through Elite's SEC filings.
You have to go back to 5/3/2017 to find Nasrat's last FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES where Nasrat's
common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company.
If you look at the S-1 and S-3 forms you will see that Elite has been very conservative with the use of their stock. Mostly comparatively small amounts issued to Lincoln Park Capital Fund to fund research and operations which is smart instead of borrowing and taking on huge debt.
Nasrat will not through the company away as he is focused on success! And success will be selling or merging the company so that is why I think he is getting the convert to common.
This company's S-# forms are not what you see for a typical OTC company - Elite is not bleeding investors - Elite is building the company!!!
Thx Chasing, Elite is doing great, again looking at the Lannett quarterly $$$ and knowing that the profit sharing doesn't really show for more likely 6 months later - LCI's BIG spike in $$ for CNS drug occurred in Jun-Dec 2019 which means a jump in $$ for ELITE ELTP in Jan-Jun 2020.
$$Millions$$ rolling in for ELITE NOW!!!
Elite as related to Lannett Central Nervous System report
Elite Adderall IR approval 7Dec2018
Lannett quarter CNS 31Dec2018 - $6,187,000
Lannett quarter CNS 31Mar2019 - $9,424,000
Lannett launch Adderall IR 16Apr2019
Lannett quarter CNS 30Jun2019 - $11,362,000
Lannett quarter CNS 30Sep2019 - $19,257,000
Elite Adderall XR approval 12Dec2019
Lannett quarter CNS 31Dec2019 - $19,331,000
Lannett launch Adderall XR 31Mar2020
Lannett quarter CNS 31Mar2020 - $18,566,000
Interesting to see Lannetts growth with CNS as related to Elites approval and launch.
I believe Jan-Mar 2020 was good $$ for Elite's Adderall IR and maybe a couple of $$ for XR.
The really big money for IR and XR will show when Elite reports 1st QTR results in August 2020.
AND GROW EXPONENTIALLY EVERY FUTURE QUARTER!!!
Jan-Mar 2020 was messed up for every business so don't read too much into it. Elite is still operating and making $millions
Bulldog, reverse merger, good catch!
Elite ensuring everything is perfect for a merger and sale!!!
Under the proposed rules, a reverse merger company would be ineligible for listing on the NYSE unless the combined entity had, immediately prior to filing its initial listing application:
traded for at least one year in the U.S. over-the-counter market, on another national securities exchange, or on a regulated foreign exchange following the consummation of the reverse merger, and (i) if a domestic issuer, filed with the SEC a Form 8-K including all of the information required by Item 2.01(f) of Form 8-K, including all required audited financial statements, or (ii) if a foreign private issuer, filed the information described in (i) above on Form 20-F;
maintained on both an absolute and an average basis for a sustained period a minimum stock price of at least $4 per share; and
timely filed with the SEC all required reports since the consummation of the reverse merger, including the filing of at least one annual report containing audited financial statements for a full fiscal year commencing on a date after the date of filing with the SEC of the filing described in the first bullet above.
In addition, a reverse merger company would be required to maintain, on both an absolute and an average basis, a minimum stock price of at least $4 per share through listing.
A key point is that the NYSE specifically exempts or excludes certain reverse merger companies from its proposed heightened listing requirements. For example, a reverse merger company listing on the NYSE in connection with an Initial Firm Commitment Underwritten Public Offering2 occurring subsequent to, or concurrently with, the reverse merger that generates net proceeds to the company of $40 million or more would be exempt.3 Similarly, companies that qualify for initial listing under the NYSE’s special purpose acquisition company, or “SPAC,” listing standards would be excluded from the NYSE’s definition of a reverse merger company.
These requirements would be in addition to the NYSE’s other listing requirements. Furthermore, the NYSE would retain the discretion to impose even more stringent requirements on a case-by-case basis. Among the factors that might trigger further NYSE scrutiny are: an inactive trading market in the company’s securities; the existence of a low number of publicly held shares that were not subject to transfer restrictions; no filing of an SEC registration statement or other filing subject to review by the SEC; and disclosure of a material weakness or weaknesses in internal controls identified by management or the company’s auditor for which an appropriate corrective action plan had not yet been implemented.
As a comparison, the Nasdaq proposed rules would prohibit a company going public by combining with a public shell from applying to list until six months after the combined entity submits all required information about the transaction, including audited financial statements, to the SEC. Further, the Nasdaq proposed rules would require that the company maintain a $4 per share bid price on at least 30 of the 60 trading days immediately prior to submitting the application. Finally, Nasdaq would not approve any reverse merger company for listing unless it had timely filed its two most recent financial reports with the SEC if it is a domestic issuer (this could be two quarterly filings or a quarterly and an annual filing) or comparable information if it is a foreign private issuer.
Did brokers screw up and not send proxy or was it Broadridge Financial not handling it correctly?
From filing -
brokers holding shares in “street name” on behalf of beneficial owners did not have discretionary authority to vote those shares on the Original Amendment Proposal without direction from the beneficial owners. However, Broadridge Financial Solutions (“Broadridge”) later determined that the Original Amendment Proposal was a routine matter under NYSE rules. As such, the proxy cards prepared by Broadridge and sent to its brokers (who, in turn, sent the ballots to their clients) clearly indicated that the Original Amendment Proposal was routine.
Again, it looks like ELITE is doing the right thing and making sure that everything is correct to meet NYSE rules.
Again, how many OTC stocks work so hard to make sure they are in compliance with NYSE rules???
Key points from filing is ELITE is following NYSE rules and protecting shareholders!
READ the filing and you will see that Elite is doing the right thing and protecting shareholders! Making sure that everything is correct for up-listing, merging, of being bought by a much bigger player.
How many OTC stock do you trying their best to make sure that they have everything right in accordance with NYSE rules???
Filing yesterday by Elite was for "an abundance of caution" and "make sure that stockholder votes in favor of the amendment have been accurately tabulated!"
NOTE: This Certificate of Amendment is identical in all material respects to a Certificate of Amendment which was filed with the Nevada Secretary of State on December 5, 2019. The amendment to the Corporation’s Articles of Incorporation set forth herein has been re-adopted by the Board of Directors and stockholders of the Corporation and is being filed out of an abundance of caution, to make sure that stockholder votes in favor of the amendment have been accurately tabulated.
The beginning of Article IV, Section 4.1 is amended and, as amended, reads as follows:
“4.1. Authorized Capital Stock. The aggregate number of shares which this Corporation shall have authority to issue is One Billion Four Hundred Forty Five Million Fifteen Thousand (1,445,015,000) shares, consisting of (a) One Billion Four Hundred Forty Five Million (1,445,000,000) shares of Common Stock, par value $0.001 per share (the “Common Stock”) and (b) Fifteen Thousand, (15,000) shares of Preferred Stock, par value $0.01 per share (the “Preferred Stock”), issuable in one or more series as hereinafter provided. A description of the classes of shares and a statement of the number of shares in each class and the relative rights, voting power, and preferences granted to and restrictions imposed upon the shares of each class are as follows:”
Elite is following NYSE rules!
The filing yesterday was "in an abundance of caution"!
In preparation for the Annual Meeting, we and our advisers assessed whether the Original Amendment Proposal was routine or non-routine under applicable New York Stock Exchange (“NYSE”) rules. That determination is based on the particular facts and circumstances associated with a proposal to increase the number of authorized shares; some share increase proposals are considered routine and others are considered non-routine. Based on our assessment, we indicated in the Annual Meeting Proxy Statement that the Original Amendment Proposal was a non-routine matter under NYSE rules and that, accordingly, brokers holding shares in “street name” on behalf of beneficial owners did not have discretionary authority to vote those shares on the Original Amendment Proposal without direction from the beneficial owners. However, Broadridge Financial Solutions (“Broadridge”) later determined that the Original Amendment Proposal was a routine matter under NYSE rules. As such, the proxy cards prepared by Broadridge and sent to its brokers (who, in turn, sent the ballots to their clients) clearly indicated that the Original Amendment Proposal was routine. The proxy cards specifically included the statement: “If you do not provide us with your voting instructions, we will vote your shares at our discretion on those proposals we are permitted to vote on by New York Stock Exchange rules.” As a result, the vote on the Original Amendment Proposal was conducted properly as a routine matter (with brokers using discretionary authority to vote in favor of the Original Amendment Proposal) and shareholder votes were tabulated correctly. The Share Increase Proposal was approved by the requisite vote under Chapter 78 of the Nevada Revised Statutes and our Articles of Incorporation and Bylaws.
We are confident that the vote on the Original Amendment Proposal was entirely proper and the Share Increase Amendment was therefore adopted by our Shareholders and is now effective. However, we recognize the inconsistent description of the nature of the proposal under NYSE rules in the Prior Proxy Statement and the proxy card. In an abundance of caution, we have determined to permit Shareholders to again approve the Share Increase Amendment, this time with a consistent classification of the proposal as routine in all solicitation materials and proxy cards. Upon Shareholder approval, we will file a new amendment to our Articles of Incorporation reflecting such approval (the “Amendment”). We have not issued any of the additional shares authorized by the Share Increase Amendment, and unless and until the Share Increase Amendment is again approved by our Shareholders, we do not intend to issue or reserve for issuance any such additional shares.
ELTP annual report in 64 days!
I think ELTP will report around June 19th.
Could be sooner but based on last year's date I think the 19th.
Thanks Chasing, yes 20 approved drugs.
Had 10 stuck in my head this morning, like 10 bagger near term.
Nasrat was Right!
It was a smart move to sell Elite's pain products because even with DEA increasing quotas - IT DOES NOT STOP THE OPIOID LAWSUITS! Also, Elite needed to stay at the 10 or less approved drugs to keep the FDA's LOWER fee rate so they had to dump the one's that they believe would not provide significant revenue compared to their currently manufactured drugs.
Elite still has OXYCONTIN ANDA on hold and could dust that off and pursue that path.
I believe Elite's move to the CNS stimulants is a much bigger and SAFER and active market to pursue.
CNS Stims are doing good for ELITE right now!
SShhhhh! Be quite! I want to buy all the ELTP shares I can at $0.06 before the next conference call report which will be the Annual report in JUNE.
UPDATE THE CHART! Who updates Elite's launch date for generic Adderall XR on the chart???